EGFR and cancer: Activation of STAT3 by JAK leads to transcriptional induction of the JAK inhibitor SOCS3 by STAT323, suggesting that STAT3 activity can oscillate in JAK-activated cancer cells and EGFR-mutated cancer cells67.